Sugi Predict

Sugi Predict / Compounds / SCHEMBL3976225

SCHEMBL3976225

SCHEMBL3976225

NCCCCCCCCCC(C(=O)O)C(=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.48
▸ TLR2 O60603 4/20 0.46
▸ FABP5 Q01469 3/20 0.44
▸ FABP7 O15540 2/20 0.44
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ MDM4 O15151 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CASP3 P42574 2/20 0.39
▸ HTR2A P28223 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL524545 1.00 KMT2A (0.48) KMT2ATLR2FABP5FABP7HDAC1
SCHEMBL525558 1.00 KMT2A (0.48) KMT2ATLR2FABP5FABP7HDAC1
SCHEMBL3426738 1.00 KMT2A (0.48) KMT2ATLR2FABP5FABP7HDAC1
SCHEMBL524835 1.00 KMT2A (0.48) KMT2ATLR2FABP5FABP7HDAC1
SCHEMBL28036073 1.00 KMT2A (0.48) KMT2ATLR2FABP5FABP7HDAC1
SCHEMBL25144 0.99 KMT2A (0.49) KMT2ATLR2FABP5FABP7HDAC1
SCHEMBL97613 0.95 KMT2A (0.50) KMT2ATLR2FABP5FABP7CA1
Succinic Acid SCHEMBL28760118 0.94 KMT2A (0.50) KMT2ATLR2FABP5FABP7HDAC1
Tetrahydrofuran SCHEMBL28301142 0.91 KMT2A (0.43) KMT2ATLR2FABP5FABP7HDAC1
SCHEMBL31658990 0.90 KMT2A (0.44) KMT2ATLR2FABP5FABP7HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026097180-A1 CMD LINKERS FOR LABEL-FREE MOLECULAR ANALYSIS, METHODS OF USE AND MANUFACTURE Nicoya Lifesciences Inc. (CA) 2026-05-15 — — WO disclosed
US-20260133187-A1 CMD Linkers for Label-Free Molecular Analysis, Methods of Use and Manufacture NICOYA LIFESCIENCES INC (CA) 2026-05-14 — — US disclosed
CN-116622005-B Polymer prodrug compound and preparation method thereof, and polymer prodrug micelle and preparation method thereof 成都中医药大学 2025-02-14 — — CN disclosed
CN-112851755-B Linear lipopeptide compound and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2023-09-01 — — CN disclosed
CN-116622005-A Polymer prodrug compound and preparation method thereof, and polymer prodrug micelle and preparation method thereof 成都普康生物科技有限公司 2023-08-22 — — CN disclosed
US-11623009-B2 Bone fracture repair by targeting of agents that promote bone healing PURDUE RESEARCH FOUNDATION (US) 2023-04-11 — — US disclosed
CN-112851755-A Linear lipopeptide compound and preparation method and application thereof 中国人民解放军军事科学院军事医学研究院 2021-05-28 — — CN disclosed
US-20210000962-A1 BONE FRACTURE REPAIR BY TARGETING OF AGENTS THAT PROMOTE BONE HEALING UNIVERSITY OF UTAH 2021-01-07 — — US disclosed
US-10744203-B2 Bone fracture repair by targeting of agents that promote bone healing PURDUE RESEARCH FOUNDATION (US) 2020-08-18 — — US disclosed
CN-104072582-B Novel peptides 乐敦制药株式会社 2020-07-28 — — CN disclosed
WO-2016196400-A1 BONE FRACTURE REPAIR BY TARGETING OF AGENTS THAT PROMOTE BONE HEALING PURDUE RESEARCH FOUNDATION (US) 2016-12-08 — — WO disclosed
US-7491741-B2 Diaminopropionic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2009-02-17 — — US disclosed
US-20070155671-A1 Diaminopropionic acid derivatives FOTOUHI NADER 2007-07-05 — — US disclosed
US-7217728-B2 Diaminopropionic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2007-05-15 — — US disclosed
US-20050080119-A1 Diaminopropionic acid derivatives FOTOUHI NADER (US) 2005-04-14 — — US disclosed
US-6858591-B2 Antibiotic AA 896 analogs WYETH HOLDINGS CORPORATION (US) 2005-02-22 — — US disclosed
US-6803384-B2 FOR THERAPY OF REPERFUSION INJURY HOFFMANN-LA ROCHE INC. 2004-10-12 — — US disclosed
US-20030087874-A1 2-amino-3-hydroxy-3-uridyl-propanoic acid ester derivatives AMERICAN CYANAMID COMPANY 2003-05-08 — — US disclosed
WO-2002086139-A1 ANTIBIOTIC AA 896 ANALOGS WYETH HOLDINGS CORPORATION (US) 2002-10-31 — — WO disclosed
US-6331640-B1 TREATMENT OF REPERFUSION INJURIES HOFFMANN-LA ROCHE INC. 2001-12-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260133187-A1 CMD Linkers for Label-Free Molecular Analysis, Methods of Use and Manufacture SPR, EPCAM, TST KMT2A 2926/4885TLR2 127/4885FABP5 195/4885
US-10744203-B2 Bone fracture repair by targeting of agents that promote bone healing CTSK, CTSG, MMP13 KMT2A 4423/4885TLR2 2831/4885FABP5 1908/4885
US-11623009-B2 Bone fracture repair by targeting of agents that promote bone healing CTSK, CTSG, MMP13 KMT2A 4423/4885TLR2 2831/4885FABP5 1908/4885
US-20030087874-A1 2-amino-3-hydroxy-3-uridyl-propanoic acid ester derivatives UMPS, METTL3, FPR3 KMT2A 3211/4885TLR2 316/4885FABP5 556/4885
US-20210000962-A1 BONE FRACTURE REPAIR BY TARGETING OF AGENTS THAT PROMOTE BONE HEALING CTSK, CTSG, MMP13 KMT2A 4423/4885TLR2 2831/4885FABP5 1908/4885
US-20070155671-A1 Diaminopropionic acid derivatives AIFM1, HIF1A, AIFM2 KMT2A 4000/4885TLR2 1162/4885FABP5 469/4885
US-20050080119-A1 Diaminopropionic acid derivatives AIFM1, HIF1A, AIFM2 KMT2A 4000/4885TLR2 1162/4885FABP5 469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback